September 11, 2024 Top Stocks For Smart Investment Choices
September 8, 2024 S&P 500 In Freefall: Is This The End Of The Bull Market?
September 6, 2024 Jobs Report Spotlight As Fed Weighs Rate Cut Decision
August 26, 2024 NVDA Earnings Report Insights
Amazon: Oracle Partnership Highlights Margin Expansion Potential
Nvidia: Why You Should Buy Before It Hits $145
Apple: Enough To Turn The Odds In Its Favor – Still Buy
AMD Is Coming For Nvidia’s AI Lead
Nvidia: Goldman Sachs’ Hilarious Downside Case
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
April 12, 2024 Improve Your Financial Status: A How-To Guide
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
Aridis Pharmaceuticals (ARDS) Stock Forecast for 2024, 2025, 2026. Sell or Buy?
Updated: September 13, 2024 (10:54)
Sector: HealthcareThe share price of Aridis Pharmaceuticals, Inc. (ARDS) now
Are you interested in Aridis Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Aridis Pharmaceuticals stock price in 2024, 2025, 2026, 2027, 2028. How much will one Aridis Pharmaceuticals share be worth in 2024 - 2028?
When should I take profit in Aridis Pharmaceuticals stock? When should I record a loss on Aridis Pharmaceuticals stock? What are analysts' forecasts for Aridis Pharmaceuticals stock? What is the future of Aridis Pharmaceuticals stock? We forecast Aridis Pharmaceuticals stock performance using neural networks based on historical data on Aridis Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Aridis Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Aridis Pharmaceuticals shares. This happens once a day.
Historical and forecast chart of Aridis Pharmaceuticals stock
The chart below shows the historical price of Aridis Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Aridis Pharmaceuticals stock price can be found in the table below.
Long-term forecasts by years.
Aridis Pharmaceuticals, Inc. Is a biopharmaceutical company specializing in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAbs) to treat infections. MABs represent a treatment approach that allows the human immune system to fight infections and is designed to overcome the disadvantages associated with current therapies, such as increased drug resistance, short response times, negative effects on the human microbiome, and lack of differentiation between treatment alternatives. Its product pipeline includes human MABs that target specific pathogens associated with bacterial infections, most notably hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP). Its leading candidate product, AR-301, targets the alpha toxin produced by the gram-positive bacteria Staphylococcus aureus, a common pathogen associated with HAP and VAP. Its AR-101 (Aerumab) is a fully human immunoglobulin M targeting P. aeruginosa serotype O11.
Aridis Pharmaceuticals daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Sep 15 | 0.00 | 0.00 | 0.00 | 3.60 |
| Sep 16 | 0.00 | 0.00 | 0.00 | 4.54 |
| Sep 17 | 0.00 | 0.00 | 0.00 | 4.96 |
| Sep 18 | 0.00 | 0.00 | 0.00 | 3.17 |
| Sep 19 | 0.00 | 0.00 | 0.00 | 5.42 |
| Sep 20 | 0.00 | 0.00 | 0.00 | 4.48 |
| Sep 21 | 0.00 | 0.00 | 0.00 | 3.33 |
| Sep 22 | 0.00 | 0.00 | 0.00 | 3.76 |
| Sep 23 | 0.00 | 0.00 | 0.00 | 3.31 |
| Sep 24 | 0.00 | 0.00 | 0.00 | 1.73 |
| Sep 25 | 0.00 | 0.00 | 0.00 | 5.41 |
| Sep 26 | 0.00 | 0.00 | 0.00 | 4.37 |
| Sep 27 | 0.00 | 0.00 | 0.00 | 4.40 |
| Sep 28 | 0.00 | 0.00 | 0.00 | 3.03 |
| Sep 29 | 0.00 | 0.00 | 0.00 | 3.88 |
| Sep 30 | 0.00 | 0.00 | 0.00 | 4.34 |
| Oct 01 | 0.00 | 0.00 | 0.00 | 2.46 |
| Oct 02 | 0.00 | 0.00 | 0.00 | 4.83 |
| Oct 03 | 0.00 | 0.00 | 0.00 | 3.27 |
| Oct 04 | 0.00 | 0.00 | 0.00 | 2.59 |
| Oct 05 | 0.00 | 0.00 | 0.00 | 3.31 |
| Oct 06 | 0.00 | 0.00 | 0.00 | 5.57 |
| Oct 07 | 0.00 | 0.00 | 0.00 | 3.64 |
| Oct 08 | 0.00 | 0.00 | 0.00 | 3.43 |
| Oct 09 | 0.00 | 0.00 | 0.00 | 2.54 |
| Oct 10 | 0.00 | 0.00 | 0.00 | 5.39 |
| Oct 11 | 0.00 | 0.00 | 0.00 | 5.33 |
| Oct 12 | 0.00 | 0.00 | 0.00 | 3.88 |
| Oct 13 | 0.00 | 0.00 | 0.00 | 2.94 |
| Oct 14 | 0.00 | 0.00 | 0.00 | 5.20 |
Aridis Pharmaceuticals Daily Price Targets
Aridis Pharmaceuticals Stock Forecast 09-15-2024.
Forecast target price for 09-15-2024: $0.00.
Negative dynamics for Aridis Pharmaceuticals shares will prevail with possible volatility of 3.475%.
Pessimistic target level: 0.00
Optimistic target level: 0.00
Aridis Pharmaceuticals Stock Forecast 09-16-2024.
Forecast target price for 09-16-2024: $0.00.
Positive dynamics for Aridis Pharmaceuticals shares will prevail with possible volatility of 4.341%.
Pessimistic target level: 0.00
Optimistic target level: 0.00
Aridis Pharmaceuticals Stock Forecast 09-17-2024.
Forecast target price for 09-17-2024: $0.00.
Negative dynamics for Aridis Pharmaceuticals shares will prevail with possible volatility of 4.725%.
Pessimistic target level: 0.00
Optimistic target level: 0.00
Aridis Pharmaceuticals Stock Forecast 09-18-2024.
Forecast target price for 09-18-2024: $0.00.
Positive dynamics for Aridis Pharmaceuticals shares will prevail with possible volatility of 3.072%.
Pessimistic target level: 0.00
Optimistic target level: 0.00
Aridis Pharmaceuticals Stock Forecast 09-19-2024.
Forecast target price for 09-19-2024: $0.00.
Positive dynamics for Aridis Pharmaceuticals shares will prevail with possible volatility of 5.140%.
Pessimistic target level: 0.00
Optimistic target level: 0.00
Aridis Pharmaceuticals Stock Forecast 09-20-2024.
Forecast target price for 09-20-2024: $0.00.
Positive dynamics for Aridis Pharmaceuticals shares will prevail with possible volatility of 4.288%.
Pessimistic target level: 0.00
Optimistic target level: 0.00
ARDS (ARDS) Monthly Stock Prediction for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Oct. | 0.00 | 0.00 | 0.00 | 15.05 |
| Nov. | 0.00 | 0.00 | 0.00 | 9.86 |
| Dec. | 0.00 | 0.00 | 0.00 | 15.56 |
Aridis Pharmaceuticals forecast for this year
Aridis Pharmaceuticals Stock Prediction for Oct 2024
An uptrend is forecast for this month with an optimal target price of $0.0000011408. Pessimistic: $0.00. Optimistic: $0.00
Aridis Pharmaceuticals Stock Prediction for Nov 2024
An uptrend is forecast for this month with an optimal target price of $0.00000118461. Pessimistic: $0.00. Optimistic: $0.00
Aridis Pharmaceuticals Stock Prediction for Dec 2024
An uptrend is forecast for this month with an optimal target price of $0.00000121493. Pessimistic: $0.00. Optimistic: $0.00
Aridis Pharmaceuticals (ARDS) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 0.00 | 0.00 | 0.00 | 13.27 |
| Feb | 0.00 | 0.00 | 0.00 | 20.87 |
| Mar | 0.00 | 0.00 | 0.00 | 16.20 |
| Apr | 0.00 | 0.00 | 0.00 | 10.60 |
| May | 0.00 | 0.00 | 0.00 | 18.49 |
| Jun | 0.00 | 0.00 | 0.00 | 21.36 |
| Jul | 0.00 | 0.00 | 0.00 | 11.16 |
| Aug | 0.00 | 0.00 | 0.00 | 19.97 |
| Sep | 0.00 | 0.00 | 0.00 | 14.37 |
| Oct | 0.00 | 0.00 | 0.00 | 16.20 |
| Nov | 0.00 | 0.00 | 0.00 | 16.67 |
| Dec | 0.00 | 0.00 | 0.00 | 14.07 |
Aridis Pharmaceuticals (ARDS) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 0.00 | 0.00 | 0.00 | 18.13 |
| Feb | 0.00 | 0.00 | 0.00 | 13.34 |
| Mar | 0.00 | 0.00 | 0.00 | 12.76 |
| Apr | 0.00 | 0.00 | 0.00 | 15.98 |
| May | 0.00 | 0.00 | 0.00 | 17.04 |
| Jun | 0.00 | 0.00 | 0.00 | 13.14 |
| Jul | 0.00 | 0.00 | 0.00 | 19.68 |
| Aug | 0.00 | 0.00 | 0.00 | 11.67 |
| Sep | 0.00 | 0.00 | 0.00 | 15.86 |
| Oct | 0.00 | 0.00 | 0.00 | 14.58 |
| Nov | 0.00 | 0.00 | 0.00 | 10.81 |
| Dec | 0.00 | 0.00 | 0.00 | 19.04 |
Aridis Pharmaceuticals information and performance
N/A
Market capitalization of the Aridis Pharmaceuticals, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ARDS shares in the company outstanding by the market price of one share.
EBITDA of Aridis Pharmaceuticals is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
